"Direct-acting antivirals for hepatitis C: What should we expect?”

When Nov 12, 2010
from 08:30 AM to 09:30 AM
Where 1131 Bioinformatics
Contact Name
Contact Phone (919) 966-2536
Add event to calendar vCal

The Center for Infectious Diseases and the Institute for Global Health and Infectious Diseases co-sponsor a weekly conference series featuring distinguished clinicians and scientists from UNC, local universities and other national and international institutions. The topics are varied and appeal to not only infectious disease specialists, but also professionals in epidemiology, public health, microbiology, biostatistics and other global health-related disciplines.

Dr. Lemon is a professor of medicine at UNC-CH.  His laboratory is interested in the innate immune responses to RNA viruses, and how these viruses have evolved to escape these host defenses. Their research focuses on the molecular pathogenesis of hepatitis C virus (HCV) - related liver diseases, including in particular HCV-associated hepatocellular carcinoma, and the development of effective therapies for hepatitis C.